Pharmacological evidence for the involvement of 1-(2-pyridinyl)-piperazine (1-PmP) in the interaction of buspirone or gepirone with noradrenergic systems.
P Giral, P Soubrie, A J Puech
Index: Eur. J. Pharmacol. 134(1) , 113-6, (1987)
Full Text: HTML
Abstract
We investigated in mice the effects of one of the principal metabolites of buspirone and gepirone, 1-(2-pyridinyl)-piperazine (1-PmP), on hypothermia and reduced locomotion induced by clonidine (0.25 and 0.06 mg/kg, respectively), tests related to brain alpha-adrenergic function. Both effects were antagonized dose dependently by 1-PmP (1-16 mg/kg i.p.). Moreover, pretreatment with proadifen (50 mg/kg) prevented the reversal by buspirone and gepirone of clonidine-induced hypothermia. This suggests that 1-PmP could be responsible for some of the apparent noradrenergic effects of buspirone and gepirone.
Related Compounds
Related Articles:
2007-08-01
[Drug Metab. Dispos. 35(8) , 1387-92, (2007)]
2008-09-15
[Bioorg. Med. Chem. 16 , 8737-44, (2008)]
2009-04-15
[Bioorg. Med. Chem. Lett. 19 , 2240-3, (2009)]
Determination of trace atmospheric isocyanate concentrations by reversed-phase high-performance liquid chromatography using 1-(2-pyridyl) piperazine reagent. Goldberg PA, et al.
[J. Chromatogr. A. 212(1) , 93-104, (1981)]
Determination of atmospheric isocyanate concentrations by high-performance thin-layer chromatography using 1-(2-pyridyl) piperazine reagent. Ellwood PA, et al.
[Analyst 106(1258) , 85-93, (1981)]